Table 2

Crude and age-adjusted and sex-adjusted incidence rates of amyloidosis, overall and in men and women

Year	Population*	SpA cohort					Non-SpA cohort
Year	Population*	Cases	Crude rate (/100,000/year)	Adjusted rate† (/100,000/year)	95% CI		Cases	Crude rate (/100,000/year)	Adjusted rate† (/100,000/year)	95% CI
1999	265 803	48	18.06	19.87	14.58	26.63	2	0.75	0.76	0.10	3.29
2000	268 777	56	20.84	22.09	16.60	29.03	2	0.74	0.83	0.10	3.40
2001	271 640	64	23.56	23.99	18.38	30.99	1	0.37	0.37	0.00	2.63
2002	277 168	67	24.17	25.28	19.54	32.38	2	0.72	0.97	0.10	3.64
2003	283 095	56	19.78	21.02	15.82	27.57	4	1.41	1.57	0.42	4.30
2004	288 220	57	19.78	21.04	15.88	27.49	3	1.04	1.04	0.20	3.42
2005	294 250	31	10.54	11.21	7.59	16.10	3	1.02	1.11	0.25	3.51
2006	299 139	35	11.70	12.89	8.98	18.05	2	0.67	0.71	0.10	2.79
2007	305 145	42	13.76	14.75	10.60	20.10	2	0.66	0.72	0.10	2.76
2008	310 053	32	10.32	11.10	7.59	15.76	6	1.94	2.15	0.77	4.78
2009	312 471	63	20.16	21.53	16.50	27.61	2	0.64	0.74	0.10	2.75
2010	313 760	64	20.40	21.51	16.56	27.51	3	0.96	1.10	0.20	3.25
2011	314 859	43	13.66	14.38	10.43	19.40	5	1.59	1.66	0.54	3.96
2012	315 013	33	10.48	10.90	7.49	15.36	2	0.63	0.68	0.10	2.47
2013	313 913	34	10.83	11.12	7.70	15.55	6	1.91	1.97	0.71	4.29
2014	312 980	36	11.50	11.64	8.17	16.10	14	4.47	4.51	2.46	7.57
2015	312 596	31	9.92	9.92	6.73	14.07	9	2.88	2.88	1.33	5.48
1999–2015	5 058 880	792	15.66	16.72			68	1.34	1.40

*Estimated population of SpA.22
†Adjusted by sex and age.
SpA, spondyloarthritis.